Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 09, 2018

SELL
$16.13 - $26.99 $3.1 Million - $5.19 Million
-192,377 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$13.55 - $21.3 $111,367 - $175,064
-8,219 Reduced 4.1%
192,377 $3.17 Million
Q4 2017

Feb 13, 2018

SELL
$12.12 - $21.65 $1.2 Million - $2.15 Million
-99,404 Reduced 33.13%
200,596 $3.8 Million
Q3 2017

Nov 14, 2017

BUY
$11.94 - $14.29 $3.58 Million - $4.29 Million
300,000
300,000 $3.67 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $235M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Awm Investment Company, Inc. Portfolio

Follow Awm Investment Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Awm Investment Company, Inc. with notifications on news.